Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CHE NYSE:DGX NYSE:LH NASDAQ:MEDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCHEChemed$458.21+0.2%$535.38$452.05▼$623.61$6.69B0.5112,199 shs111,243 shsDGXQuest Diagnostics$168.27+0.7%$175.15$137.71▼$182.38$18.65B0.491.00 million shs1.36 million shsLHLabcorp$247.14+0.5%$253.69$205.98▼$265.72$20.59B0.82652,474 shs645,080 shsMEDPMedpace$319.16+1.4%$307.15$250.05▼$441.27$9.05B1.47379,253 shs323,670 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCHEChemed+0.12%-1.73%-16.47%-21.07%-16.61%DGXQuest Diagnostics+0.73%-1.88%-5.97%+2.76%+13.28%LHLabcorp+0.49%-2.38%-4.71%+13.76%+14.49%MEDPMedpace+1.38%-2.77%+7.13%+7.72%-26.96%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCHEChemed4.982 of 5 stars3.55.03.34.92.02.52.5DGXQuest Diagnostics4.9506 of 5 stars3.32.04.24.72.82.52.5LHLabcorp4.6242 of 5 stars3.32.02.54.22.52.51.3MEDPMedpace3.8868 of 5 stars1.11.00.04.62.94.22.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCHEChemed 3.00Buy$645.0040.76% UpsideDGXQuest Diagnostics 2.69Moderate Buy$185.7310.38% UpsideLHLabcorp 2.57Moderate Buy$276.3811.83% UpsideMEDPMedpace 2.21Hold$344.828.04% UpsideCurrent Analyst Ratings BreakdownLatest CHE, MEDP, LH, and DGX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/10/2025LHLabcorpHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold7/10/2025LHLabcorpHSBCSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$260.007/9/2025LHLabcorpEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$260.00 ➝ $285.006/30/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$674.00 ➝ $640.006/30/2025CHEChemedBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$708.00 ➝ $650.006/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingCautious ➝ Cautious6/25/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetEqual Weight ➝ Equal Weight$250.00 ➝ $275.006/24/2025MEDPMedpaceBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOutperform ➝ Equal Weight$300.006/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.00(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCHEChemed$2.43B2.76$25.77 per share17.78$74.35 per share6.16DGXQuest Diagnostics$9.87B1.90$13.60 per share12.37$61.38 per share2.74LHLabcorp$13.01B1.59$22.51 per share10.98$96.27 per share2.57MEDPMedpace$2.11B4.35$14.14 per share22.57$26.56 per share12.02Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCHEChemed$302M$20.5322.3219.672.2012.40%27.58%18.96%7/29/2025 (Estimated)DGXQuest Diagnostics$871M$7.9121.2716.042.338.81%15.11%6.65%7/22/2025 (Estimated)LHLabcorp$746M$8.6528.5714.091.565.55%15.27%6.97%7/24/2025 (Estimated)MEDPMedpace$404.39M$13.1024.3623.365.6919.31%54.36%20.81%7/21/2025 (Confirmed)Latest CHE, MEDP, LH, and DGX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025CHEChemed$6.02N/AN/AN/A$650.60 millionN/A7/24/2025Q2 2025LHLabcorp$4.12N/AN/AN/A$3.49 billionN/A7/22/2025Q2 2025DGXQuest Diagnostics$2.56N/AN/AN/A$2.73 billionN/A7/21/2025Q2 2025MEDPMedpace$3.01N/AN/AN/A$537.70 millionN/A4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 million4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billion4/21/2025Q1 2025MEDPMedpace$3.06$3.67+$0.61$3.67$528.38 million$558.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCHEChemed$2.000.44%N/A9.74%16 YearsDGXQuest Diagnostics$3.201.90%N/A40.46%14 YearsLHLabcorp$2.881.17%N/A33.29%N/AMEDPMedpaceN/AN/AN/AN/AN/ALatest CHE, MEDP, LH, and DGX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/10/2025LHLabcorpquarterly$0.721.11%8/28/20259/11/20255/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20255/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCHEChemedN/A1.731.70DGXQuest Diagnostics0.841.441.31LHLabcorp0.681.841.60MEDPMedpaceN/A0.730.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCHEChemed95.85%DGXQuest Diagnostics88.06%LHLabcorp95.94%MEDPMedpace77.98%Insider OwnershipCompanyInsider OwnershipCHEChemed3.29%DGXQuest Diagnostics8.16%LHLabcorp0.84%MEDPMedpace20.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCHEChemed15,69514.63 million14.15 millionOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableLHLabcorp70,00083.70 million83.00 millionOptionableMEDPMedpace5,90028.74 million22.91 millionOptionableCHE, MEDP, LH, and DGX HeadlinesRecent News About These CompaniesMedpace (MEDP) Beats Stock Market Upswing: What Investors Need to KnowJuly 17 at 7:16 PM | zacks.comSegall Bryant & Hamill LLC Purchases 16,872 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)July 17 at 6:52 AM | marketbeat.comDakota Wealth Management Grows Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP)July 17 at 5:47 AM | marketbeat.comKornitzer Capital Management Inc. KS Buys Shares of 8,675 Medpace Holdings, Inc. (NASDAQ:MEDP)July 16 at 7:08 AM | marketbeat.comEdgestream Partners L.P. Raises Stock Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP)July 15 at 5:55 AM | marketbeat.comEnvestnet Asset Management Inc. Reduces Stake in Medpace Holdings, Inc. (NASDAQ:MEDP)July 15 at 4:12 AM | marketbeat.comMedpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseJuly 14, 2025 | zacks.comRice Hall James & Associates LLC Sells 1,356 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)July 14, 2025 | marketbeat.comCerity Partners LLC Sells 3,695 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)July 14, 2025 | marketbeat.comMedpace (MEDP) Projected to Post Quarterly Earnings on MondayJuly 14, 2025 | marketbeat.comOxbow Advisors LLC Buys Shares of 8,865 Medpace Holdings, Inc. (NASDAQ:MEDP)July 13, 2025 | marketbeat.comStephens Investment Management Group LLC Cuts Stock Position in Medpace Holdings, Inc. (NASDAQ:MEDP)July 13, 2025 | marketbeat.comBank of New York Mellon Corp Has $59.91 Million Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP)July 12, 2025 | marketbeat.comQ2 Earnings Forecast for Medpace Issued By Leerink PartnrsJuly 12, 2025 | americanbankingnews.com4,140 Shares in Medpace Holdings, Inc. (NASDAQ:MEDP) Acquired by Covey Capital Advisors LLCJuly 11, 2025 | marketbeat.comPrincipal Financial Group Inc. Has $17.65 Million Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP)July 11, 2025 | marketbeat.comMedpace (MEDP) Exceeds Market Returns: Some Facts to ConsiderJuly 10, 2025 | zacks.comLeerink Partnrs Has Bullish Forecast for Medpace Q2 EarningsJuly 10, 2025 | marketbeat.comFY2025 EPS Estimates for Medpace Lifted by Leerink PartnrsJuly 10, 2025 | americanbankingnews.comMEDP - Medpace Holdings Inc Executives | MorningstarJuly 9, 2025 | morningstar.comMFY2025 EPS Estimates for Medpace Boosted by Leerink PartnrsJuly 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedBy Jeffrey Neal Johnson | June 18, 2025View 3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedJoby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?By Jeffrey Neal Johnson | July 14, 2025View Joby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?NVIDIA’s Stock Price Hits New Highs: This Is What’s NextBy Thomas Hughes | June 26, 2025View NVIDIA’s Stock Price Hits New Highs: This Is What’s NextThe Meteoric Rise of Rocket Lab: A Space Stock to WatchBy Ryan Hasson | July 11, 2025View The Meteoric Rise of Rocket Lab: A Space Stock to WatchCHE, MEDP, LH, and DGX Company DescriptionsChemed NYSE:CHE$458.21 +0.92 (+0.20%) Closing price 07/17/2025 03:59 PM EasternExtended Trading$457.62 -0.60 (-0.13%) As of 07/17/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Quest Diagnostics NYSE:DGX$168.27 +1.24 (+0.74%) Closing price 07/17/2025 03:59 PM EasternExtended Trading$167.50 -0.77 (-0.46%) As of 07/17/2025 04:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.Labcorp NYSE:LH$247.14 +1.16 (+0.47%) Closing price 07/17/2025 03:59 PM EasternExtended Trading$247.24 +0.10 (+0.04%) As of 07/17/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Medpace NASDAQ:MEDP$319.16 +4.33 (+1.38%) Closing price 07/17/2025 04:00 PM EasternExtended Trading$314.83 -4.33 (-1.36%) As of 07/17/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
